Siemens Atellica IM Quantitative HBsAg (QHBs) - HSA Registration DE0506659
Access comprehensive regulatory information for Siemens Atellica IM Quantitative HBsAg (QHBs) in the Singapore medical device market through Pure Global AI's free database. This CLASS C IVD medical device is registered under HSA registration number DE0506659 and owned by Siemens Healthcare Diagnostics Products Limited. The device was registered on February 17, 2022.
This page provides complete registration details including product owner information, registrant details, importer information, and regulatory compliance data from the official Singapore HSA medical device database. Pure Global AI offers free access to Singapore's complete medical device registry, helping global MedTech companies navigate HSA regulations efficiently.
The Atellica® IM Quantitative HBsAg (QHBs) assay is for in vitro diagnostic use in the quantitative determination of hepatitis B surface antigen (HBsAg) in human serum and plasma (dipotassium EDTA and lithium heparin) that are confirmed positive for HBsAg using the Atellica® Analyzer